alexa
Reach Us +44-1625-708989
Sonali Kurup | OMICS International
ISSN: 2470-6965

Malaria Control & Elimination
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Sonali Kurup

Sonali Kurup  Sonali Kurup 
Medicinal Chemistry 
Roosevelt University 
Schaumburg

Biography

 Sonali Kurup joined Roosevelt University as Assistant Professor of Medicinal Chemistry in 2011. Prior to this, I completed my doctoral studies (2002-2009) in medicinal chemistry at Duquesne University, under the supervision of Professor Aleem Gangjee and postdoctoral training (2008- 2011) with Professor Matthew Soellner at the University of Michigan. My dissertation focused on the rational design and synthesis of novel anticancer agents targeting receptor tyrosine kinases, the folate pathway, microtubules and Hsp90. This involved the application of molecular modeling techniques in drug design and development of novel multi-step methodologies for the synthesis of target compounds. During my postdoctoral training, I was involved in developing a novel fragment-based methodology for the identification of substrate competitive kinase inhibitors targeting the non-receptor tyrosine kinases c-Src and c-Abl. Starting from peptidic inhibitors, small molecule inhibitors with submicromolar inhibition were identified.

Research Interest

Design, Synthesis and Evaluation of Multi-targeted HIV Inhibitors A single scaffold is being developed to incorporate an overlapping set of key recognition elements to inhibit HIV reverse transcriptase and HIV integrase enzymes.
Fragment Based Screening Approaches for the Identification of Novel Protease Inhibitors

Publications

Global Speakers in the subject

Global Experts in the subject

Top